These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 27712567)

  • 1. Development and Optimization of Controlled Porosity Osmotic Tablets of Lamotrigine Solid Dispersion.
    Patel GC; Kasarwala M
    Recent Pat Drug Deliv Formul; 2016; 10(3):222-234. PubMed ID: 27712567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of controlled release osmotic pump tablet of glipizide solid dispersion.
    Patel GC; Asodaria KV; Patel HP; Shah DR
    Curr Drug Deliv; 2014; 11(6):817-27. PubMed ID: 23859357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production and
    Ma C; Huang Z; Zhu Y; Chen X; Singh V; Huang Y; Pan X; Wu C
    Pharmazie; 2017 Sep; 72(9):511-517. PubMed ID: 29441977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and Evaluation of a Once-Daily Controlled Porosity Osmotic Pump of Tapentadol Hydrochloride.
    Thakkar HP; Pancholi N; Patel CV
    AAPS PharmSciTech; 2016 Oct; 17(5):1248-60. PubMed ID: 26677859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applicability of (SBE)7m-beta-CD in controlled-porosity osmotic pump tablets (OPTs).
    Okimoto K; Tokunaga Y; Ibuki R; Irie T; Uekama K; Rajewski RA; Stella VJ
    Int J Pharm; 2004 Nov; 286(1-2):81-8. PubMed ID: 15501004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled porosity solubility modulated osmotic pump tablets of gliclazide.
    Banerjee A; Verma PR; Gore S
    AAPS PharmSciTech; 2015 Jun; 16(3):554-68. PubMed ID: 25378281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The delivery mechanism of micro-porous osmotic pump tablets].
    Zhao XL; Li Q; Gong XF; Li SM
    Yao Xue Xue Bao; 2007 Feb; 42(2):226-30. PubMed ID: 17518057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design of a 24-hour controlled porosity osmotic pump system containing PVP: formulation variables.
    Yakubu R; Peh KK; Tan YT
    Drug Dev Ind Pharm; 2009 Dec; 35(12):1430-8. PubMed ID: 19929202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation Development and Optimization of Matrix Tablet of Tramadol Hydrochloride.
    Deb P; Singha J; Chanda I; Chakraborty P
    Recent Pat Drug Deliv Formul; 2017; 11(1):19-27. PubMed ID: 27712568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of an osmotic pump system for controlled delivery of diclofenac sodium.
    Emara LH; Taha NF; Badr RM; Mursi NM
    Drug Discov Ther; 2012 Oct; 6(5):269-77. PubMed ID: 23229148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of excipients, drugs, and osmotic agent in the inner core on the time-controlled disintegration of compression-coated ethylcellulose tablets.
    Lin SY; Lin KH; Li MJ
    J Pharm Sci; 2002 Sep; 91(9):2040-6. PubMed ID: 12210050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monolithic osmotic tablet containing solid dispersion of 10-hydroxycamptothecin.
    Chen H; Jiang G; Ding F
    Drug Dev Ind Pharm; 2009 Feb; 35(2):131-7. PubMed ID: 19169941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and evaluation of osmotic pump-based controlled release system of Ambroxol Hydrochloride.
    Cheng X; Sun M; Gao Y; Cao F; Zhai G
    Pharm Dev Technol; 2011 Aug; 16(4):392-9. PubMed ID: 20429827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and evaluation of microporous membrane coated matrix tablets for a highly water soluble drug.
    Mishra M; Mishra B
    Chem Pharm Bull (Tokyo); 2010 Jul; 58(7):995-1000. PubMed ID: 20606356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel solubility-modulated granules through porosity osmotic pump for controlled carvedilol delivery.
    Song QL; Li P; Li YM
    Pharm Dev Technol; 2012; 17(6):666-76. PubMed ID: 21486184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and Evaluation of Bilayer Pump Tablet of Flurbiprofen Solid Dispersion for Zero-Order Controlled Delivery.
    Cheng L; Li T; Dong L; Wang X; Huo Q; Wang H; Jiang Z; Shan X; Pan W; Yang X
    J Pharm Sci; 2018 May; 107(5):1434-1442. PubMed ID: 29291415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design porosity osmotic tablet for delivering low and pH-dependent soluble drug using an artificial neural network.
    Patel A; Mehta T; Patel M; Patel K; Patel N
    Curr Drug Deliv; 2012 Sep; 9(5):459-67. PubMed ID: 22746271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel asymmetric membrane osmotic pump capsule with in situ formed delivery orifices for controlled release of gliclazide solid dispersion system.
    Yang Y; Zhao Z; Wang Y; Yang L; Liu D; Yang X; Pan W
    Int J Pharm; 2016 Jun; 506(1-2):340-50. PubMed ID: 27132166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. D-optimal mixture design inspired modified release tablet formulation of lamotrigine for the treatment of seizures: An in-depth characterization.
    Atneriya U; Sainy J; Chidrawar VR; Sharma M; Maheshwari R
    Ann Pharm Fr; 2024 May; 82(3):446-463. PubMed ID: 37866637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of pore-formers and plasticizers on the release kinetic of diltiazem hydrochloride from the controlled porosity osmotic pumps.
    Shokri J; H Zarrintan M; Ghanbarzadeh S; Arash Z; Farahani A; Adibkia K
    Drug Res (Stuttg); 2013 Aug; 63(8):414-9. PubMed ID: 23599037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.